What's new

Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 26, Status: Authorised

Apr 22, 2025 - 16:31
 0
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

STAT+: An ‘insane’ calculus: A pharma company raised price for a rare disease dr...

Next Article

Haven Energy offers no-cost solar, batteries to income-qualified California cust...

Related Posts

PRAC recommendations on signals adopted at the 10-13 Ma...

Apr 7, 2025  0

Methodology Working Party

Methodology Working Party

Feb 9, 2025  0

Orphan designation: adeno-associated virus sector serotype rh74 containing the human SGCG gene Treatment of limb-girdle muscular dystrophy, 27/02/2025 Positive

Orphan designation: adeno-associated virus sector serot...

Mar 11, 2025  0